Skip to content

Treatment of Adult Men with Metastatic Castration-resistant Prostate Cancer Whose Disease Has Progressed on or After Docetaxel Therapy

The medicines shown here belong to the Prostate Health category and are used for managing Treatment of Adult Men with Metastatic Castration-resistant Prostate Cancer Whose Disease Has Progressed on or After Docetaxel Therapy. Products containing Enzalutamide feature in this group.

Xtandi

Enzalutamide

40mg

Blocks androgen receptors and inhibits androgen receptor signalling to slow prostate cancer growth and delay disease progression in adult men with prostate cancer.

From$19.02/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.